| Literature DB >> 26447460 |
Shige Wang1,2, Yu Chen1, Xiang Li3, Wei Gao4, Linlin Zhang1, Jun Liu3, Yuanyi Zheng4, Hangrong Chen1, Jianlin Shi1.
Abstract
MoS2 nanosheets and a doxorubicin (DOX)-containing poly (lactic-co-glycolic acid) (PLGA)/MoS2 /DOX composite implant are successfully constructed based on the unique phase-changing behavior of PLGA/MoS2 /DOX oleosol within tumors. The fast phase transformation can firmly restrict MoS2 and DOX within tumors, and the integrated MoS2 and DOX can endow the implant with high synergistic photothermal and chemotherapeutic efficiency against tumors.Entities:
Keywords: composite implants; drug delivery; molybdenum disulfides; photothermal therapies; synergistic tumor therapy
Mesh:
Substances:
Year: 2015 PMID: 26447460 DOI: 10.1002/adma.201503869
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849